Abivax S.A. Cash Flows From Used In Investing Activities
Abivax S.A. (ABVX) reported Cash Flows From Used In Investing Activities of -EUR 8.19 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2026-03-23
- Abivax S.A. cash flows from used in investing activities for the quarter ending 2025-12-31 was -12.74M EUR, a 2391.73% decline year-over-year.
- Abivax S.A. cash flows from used in investing activities for the quarter ending 2025-09-30 was 3.28M EUR, a 87.64% increase year-over-year.
- Abivax S.A. cash flows from used in investing activities for the quarter ending 2025-06-30 was 187.00K EUR, a 98.38% decline year-over-year.
- Abivax S.A. cash flows from used in investing activities for the quarter ending 2025-03-31 was 1.08M EUR, a 43.08% decline year-over-year.
| Period end | Cash Flows From Used In Investing Activities 3 month | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 9 month | Cash Flows From Used In Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | -12.74M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | -9.46M EUR derived: sum of 2 quarters · filed 2026-03-23 | -9.28M EUR derived: sum of 3 quarters · filed 2026-03-23 | -8.19M EUR 20-F · filed 2026-03-23 |
| 2025-09-30 | 3.28M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | 3.47M EUR derived: sum of 2 quarters · filed 2025-12-15 | 4.55M EUR 6-K · filed 2025-12-15 | 5.11M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-06-30 | 187.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08 | 1.27M EUR 6-K · filed 2025-09-08 | 1.82M EUR derived: sum of 3 quarters · filed 2026-03-23 | 3.57M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2025-03-31 | 1.08M EUR 6-K · filed 2025-06-02 | 1.64M EUR derived: sum of 2 quarters · filed 2026-03-23 | 3.39M EUR derived: sum of 3 quarters · filed 2026-03-23 | 14.94M EUR derived: sum of 4 quarters · filed 2026-03-23 |
| 2024-12-31 | 556.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-23 | 2.30M EUR derived: sum of 2 quarters · filed 2026-03-23 | 13.86M EUR derived: sum of 3 quarters · filed 2026-03-23 | 15.76M EUR 20-F · filed 2026-03-23 |
| 2024-09-30 | 1.75M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-12-15 | 13.30M EUR derived: sum of 2 quarters · filed 2025-12-15 | 15.21M EUR 6-K · filed 2025-12-15 | |
| 2024-06-30 | 11.56M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-09-08 | 13.46M EUR 6-K · filed 2025-09-08 | ||
| 2024-03-31 | 1.90M EUR 6-K · filed 2025-06-02 | |||
| 2023-12-31 | -8.10M EUR 20-F · filed 2026-03-23 | |||
| 2022-12-31 | -12.03M EUR 20-F · filed 2025-03-24 | |||
| 2021-12-31 | -6.23M EUR 20-F · filed 2024-04-05 |